News

Drug Delivery Business16h
Medtronic submits interoperable insulin pump to FDA to advance collaboration with Abbott
Medtronic (NYSE:MDT) announced today that it submitted 510(k) applications to the FDA seeking clearance for an interoperable ...
Drug Delivery Business2d
Ypsomed to sell diabetes business, insulin delivery tech to TecMed for $517.7M
Ypsomed announced today that it agreed to sell its diabetes care business to TecMed for up to approximately $517.7 million ...
Drug Delivery Business2d
Biolinq closes $100M Series C funding round for biosensor platform
Biolinq has completed its pivotal trial and submitted its wearable biosensor to the FDA for regulatory review.
Drug Delivery Business3d
Abbott launches universal FreeStyle Libre CGM app in U.S.
Abbott recently launched a smartphone app that works with both its FreeStyle Libre 2 and FreeStyle Libre 3 CGM systems.
Drug Delivery Business3d
Medtronic wins FDA nod for new Simplera Sync CGM with MiniMed 780G
Medtronic (NYSE:MDT) announced that the FDA approved its Simplera Sync continuous glucose monitor for use with the.
Drug Delivery Business6d
Tidepool achieves new certification for open-source quality management system
Tidepool announced today that it secured a new certification for its open-source quality management system, known as qmsOS.